Zdrowie i gospodarka · 29/10/2008

FDA Requests Public Comment on Waiver of Bioequivalence Demonstration for Generic Solids and Type A Medications

The Food and Drug Administration (FDA) is seeking public input on proposed changes to its procedures for determining bioequivalence for generic solid oral medications and Type A medicated products, which would exempt certain products from in vivo demonstration requirements.